Literature DB >> 20823996

Anticoagulation in a Neurosurgical Patient with Heparin-Induced Thrombocytopenia Type II with Argatroban and Fondaparinux after Clipping of an Intracranial Aneurysm.

Thomas Kerz1, Helmut Schinzel.   

Abstract

BACKGROUND: Therapeutic anticoagulation in patients after a major neurosurgical procedure remains critical because of the risk of a major intracranial bleed. Novel drugs could play a beneficial role in this setting. CASE REPORT: We describe a patient with heparin-induced thrombocytopenia type II and pulmonary embolism who was anticoagulated with argatroban and, later, with fondaparinux. No intracranial bleeding was detected when anticoagulation was performed with argatroban and, later, fondaparinux.
CONCLUSION: Both substances could have therapeutic potential in this context.

Entities:  

Year:  2009        PMID: 20823996      PMCID: PMC2928829          DOI: 10.1159/000205964

Source DB:  PubMed          Journal:  Transfus Med Hemother        ISSN: 1660-3796            Impact factor:   3.747


  8 in total

1.  Heparin-induced thrombocytopenia associated with fondaparinux.

Authors:  Theodore E Warkentin; Brian T Maurer; Richard H Aster
Journal:  N Engl J Med       Date:  2007-06-21       Impact factor: 91.245

Review 2.  Heparin-induced thrombocytopenia: a review.

Authors:  Bruno Girolami; Antonio Girolami
Journal:  Semin Thromb Hemost       Date:  2006-11       Impact factor: 4.180

Review 3.  Fondaparinux for thromboembolic treatment and prophylaxis of heparin-induced thrombocytopenia.

Authors:  Leigh E Efird; Denise R Kockler
Journal:  Ann Pharmacother       Date:  2006-06-20       Impact factor: 3.154

Review 4.  Argatroban: a direct thrombin inhibitor with reliable and predictable anticoagulant actions.

Authors:  Ginés Escolar; Jordi Bozzo; Santiago Maragall
Journal:  Drugs Today (Barc)       Date:  2006-04       Impact factor: 2.245

5.  Serologic results in >1000 patients with suspected heparin-induced thrombocytopenia.

Authors:  Suresh G Shelat; Anne Tomaski; Eleanor S Pollak
Journal:  Clin Appl Thromb Hemost       Date:  2007-09-25       Impact factor: 2.389

6.  Argatroban anticoagulation in patients with acute ischemic stroke (ARGIS-1): a randomized, placebo-controlled safety study.

Authors:  Marian P LaMonte; Marshall L Nash; David Z Wang; Andrew R Woolfenden; John Schultz; Marcie J Hursting; Philip M Brown
Journal:  Stroke       Date:  2004-05-20       Impact factor: 7.914

7.  Frequency of heparin-induced thrombocytopenia in critical care patients.

Authors:  Arun K Verma; Marc Levine; Stephen J Shalansky; Cedric J Carter; John G Kelton
Journal:  Pharmacotherapy       Date:  2003-06       Impact factor: 4.705

Review 8.  Laboratory diagnosis of immune heparin-induced thrombocytopenia.

Authors:  Theodore E Warkentin; Nancy M Heddle
Journal:  Curr Hematol Rep       Date:  2003-03
  8 in total
  1 in total

1.  Clinically Oriented Research in Transfusion Medicine.

Authors:  Petra Krakowitzky; Walter Sibrowski
Journal:  Transfus Med Hemother       Date:  2009       Impact factor: 3.747

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.